$ACAD ACADIA Pharmaceuticals Inc- Base- Base resolution imminent.
- $19.13 / $19.44 / $19.77 / $20.00 / $20.31
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.36 USD
226.45 M USD
957.80 M USD
165.49 M
About ACADIA Pharmaceuticals Inc.
Sector
Industry
CEO
Catherine Owen Adams
Website
Headquarters
San Diego
Founded
1993
FIGI
BBG000BHG9K0
ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.
ACAD Stock Soared to a Four-Month High.
Acadia Pharmaceuticals shares are trading higher Wednesday after the company won summary judgement in a patent suit. Just then Acadia Surged upto 33% in regards to the news.
Acadia Pharmaceuticals (ACAD) notched a win in a patent battle Wednesday pertaining to its Parkinson's drug, Nuplazid. ACAD
$ACAD will need to finish correction before starting a long
NASDAQ:ACAD - expecting a turn 180 degree and beginning of the moddle-term long position.
NASDAQ:ACAD :: HKEX:18 -> HKEX:30 ::67%::Oct 2023
Does not constitute a recommendation.
#investing #stocks #idea #forecast #furoreggs
Please, subscribe and challenge my point of view )
ACAD - Breakout IdeaA small channel up within a larger channel down
I expect a breakout up to the top of the larger down channel
This works well with a curved bowl recovery structure
ACADIA Pharmaceuticals Inc - Biotech Run Up: Catalyst 3/12/23ACADIA Pharmaceuticals Inc. has a significant catalyst event scheduled for March 12th, 2023. After a prolonged decline, the stock has rebounded and broken out of a downward trend, indicating potential for upward movement. Investors should keep an eye on this biotech company as it approaches the cata
Acadia Beautiful tap of long term support could signal a large double bottom. If we can pop and close above 20$ could bring us to retest upper resiatnce of 25 or 27$. If we fail 20$ I would look for a retest or 16$ range huge buy volume came in at 16$ I wouldn’t chase this but keep on radar for a pull bac
ACADIABREAKING OUT OF ANOTHER bullflag or bull poennat break 24$ and we are looking foir a nice push!! target 27.55
Acadia I had this mapped out but I misse the trade! Damn! What do I do!? We’ll I’ll tell you, I don’t come in here now and FOMO. I draw some fibs and look for previous resiatnce.
I see a lot o wicks and no candles closing above .382 from recent high to low of 21.07
This price is 22.48
I have some bid
Big move coming, which way is the question..NASDAQ:ACAD .. I have been along with this one for a few months now. Around this price range is where we see big-time moves. This $21.88 level is a key level for this stock. It has been in a downtrend since it hit its 3 month high at the end of December. With how the market has been to begin this y
ACAD, correcite move formingACAD seems to me it finished the first wave of an A-B-C zig-zag pattern, we should expect now a 3 waves move to the upside with price not retracing more than 61,8% Fib . Correction might take us to 6,13$-3,53 $ range.
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of ACAD is 14.84 USD — it has increased by 1.92% in the past 24 hours. Watch ACADIA Pharmaceuticals Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange ACADIA Pharmaceuticals Inc. stocks are traded under the ticker ACAD.
ACAD stock has risen by 0.27% compared to the previous week, the month change is a −12.12% fall, over the last year ACADIA Pharmaceuticals Inc. has showed a −13.37% decrease.
We've gathered analysts' opinions on ACADIA Pharmaceuticals Inc. future price: according to them, ACAD price has a max estimate of 37.00 USD and a min estimate of 11.00 USD. Watch ACAD chart and read a more detailed ACADIA Pharmaceuticals Inc. stock forecast: see what analysts think of ACADIA Pharmaceuticals Inc. and suggest that you do with its stocks.
ACAD reached its all-time high on Jul 7, 2020 with the price of 58.72 USD, and its all-time low was 0.65 USD and was reached on Nov 12, 2010. View more price dynamics on ACAD chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ACAD stock is 2.78% volatile and has beta coefficient of 0.83. Track ACADIA Pharmaceuticals Inc. stock price on the chart and check out the list of the most volatile stocks — is ACADIA Pharmaceuticals Inc. there?
Today ACADIA Pharmaceuticals Inc. has the market capitalization of 2.48 B, it has decreased by −10.48% over the last week.
Yes, you can track ACADIA Pharmaceuticals Inc. financials in yearly and quarterly reports right on TradingView.
ACADIA Pharmaceuticals Inc. is going to release the next earnings report on May 13, 2025. Keep track of upcoming events with our Earnings Calendar.
ACAD earnings for the last quarter are 0.86 USD per share, whereas the estimation was 0.22 USD resulting in a 298.68% surprise. The estimated earnings for the next quarter are −0.02 USD per share. See more details about ACADIA Pharmaceuticals Inc. earnings.
ACADIA Pharmaceuticals Inc. revenue for the last quarter amounts to 259.60 M USD, despite the estimated figure of 255.61 M USD. In the next quarter, revenue is expected to reach 239.53 M USD.
ACAD net income for the last quarter is 143.74 M USD, while the quarter before that showed 32.77 M USD of net income which accounts for 338.71% change. Track more ACADIA Pharmaceuticals Inc. financial stats to get the full picture.
No, ACAD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 15, 2025, the company has 654 employees. See our rating of the largest employees — is ACADIA Pharmaceuticals Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ACADIA Pharmaceuticals Inc. EBITDA is 100.16 M USD, and current EBITDA margin is 10.46%. See more stats in ACADIA Pharmaceuticals Inc. financial statements.
Like other stocks, ACAD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ACADIA Pharmaceuticals Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ACADIA Pharmaceuticals Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ACADIA Pharmaceuticals Inc. stock shows the strong sell signal. See more of ACADIA Pharmaceuticals Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.